This code is indispensable in transfusion medicine, as it ensures the safety and viability of blood components by reducing the risk of transfusion-associated graft-versus-host disease (TA-GVHD). Irradiation is a critical step in the preparation of blood products for specific patient populations, such as immunocompromised or neonatal patients.
Under what category does Blood Product Irradiation fall?
Category I
What is the billing unit for Blood Product Irradiation?
Per procedure
Modifiers
Modifiers can be applied as needed to specify particular details of the irradiation procedure.
Clinical use
CPT code 86945 is clinically used to irradiate blood products, reducing the risk of TA-GVHD. This is crucial for ensuring the safety of blood components when they are intended for use in immunocompromised patients, neonates, and other vulnerable populations.
Documentation
Proper documentation should encompass patient information, the rationale for irradiation, details of the irradiation procedure, and any relevant test results. Accurate record-keeping is crucial for the safety and effectiveness of blood products.